TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 0 | -5 | -14 | -27 | -36 | -35 | -23 |
| S | %wins | 50 | 100 | 100 | 100 | 100 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/2/04 14:09 | 5/28/04 | DSCO | Discovery Laboratories Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Cooper John G | PA | O | EVP,CFO | S | -108 | 10.78 | 0 | -10 | -47 | 11 | D | 167 | 29 | -10 | -8 | 12 | 10 | 4 | -1 | -5 | -17 | -28 | -37 | -35 | |
5/28/04 11:42 | 5/27/04 | DSCO | Discovery Laboratories Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Cooper John G | PA | O | EVP,CFO | S.d | -210 | 10.51 | 0 | -20 | -48 | 21 | D | 181 | 34 | -10 | -11 | 5 | 8 | 8 | 1 | -5 | -11 | -26 | -34 | -34 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |